Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Mussetti

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
British Journal of Haematology|April 29, 2026
Prospective implementation of the HCT frailty scale in adults with lymphoproliferative syndromes candidates for autologous haematopoietic stem cell transplantation: Results from a multicentre GETH-TC studyJavier Cornago, Mónica Baile, Marina Acera, et al.
Hemasphere|May 22, 2024
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapyGloria Iacoboni, Josu Iraola-Truchuelo, Maeve O'Reilly, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2015
Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term SurvivorsEvgeny Klyuchnikov, Ulrike Bacher, Nicolaus M Kröger, et al.
Cancer|February 13, 2020
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantationDeepa Jagadeesh, Navneet S Majhail, Yizeng He, et al.
Cancer|April 13, 2018
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failureSonali M Smith, James Godfrey, Kwang Woo Ahn, et al.
Blood Advances|January 13, 2026
Allogeneic HCT as Consolidation in B-cell Lymphomas After Exposure to Bispecific Antibodies: A GETH-TC StudyMarta Peña, Giulia Losi, Víctor Navarro, et al.
Bone Marrow Transplantation|December 11, 2024
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TCVirginia Escamilla-Gómez, Valentín García Gutiérrez, Patricia Alcalde-Mellado, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2015
Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin LymphomaVeronika Bachanova, Linda J Burns, Kwang Woo Ahn, et al.
Bone Marrow Transplantation|April 19, 2023
Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART eraAlberto Mussetti, Leyre Bento, Mariana Bastos-Oreiro, et al.
Transplantation and Cellular Therapy|April 27, 2025
Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell LymphomaRoni Shouval, Christopher Strouse, Soyoung Kim, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
British Journal of Haematology|April 29, 2026
Prospective implementation of the HCT frailty scale in adults with lymphoproliferative syndromes candidates for autologous haematopoietic stem cell transplantation: Results from a multicentre GETH-TC studyJavier Cornago, Mónica Baile, Marina Acera, et al.
Hemasphere|May 22, 2024
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapyGloria Iacoboni, Josu Iraola-Truchuelo, Maeve O'Reilly, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2015
Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term SurvivorsEvgeny Klyuchnikov, Ulrike Bacher, Nicolaus M Kröger, et al.
Cancer|February 13, 2020
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantationDeepa Jagadeesh, Navneet S Majhail, Yizeng He, et al.
Cancer|April 13, 2018
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failureSonali M Smith, James Godfrey, Kwang Woo Ahn, et al.
Blood Advances|January 13, 2026
Allogeneic HCT as Consolidation in B-cell Lymphomas After Exposure to Bispecific Antibodies: A GETH-TC StudyMarta Peña, Giulia Losi, Víctor Navarro, et al.
Bone Marrow Transplantation|December 11, 2024
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TCVirginia Escamilla-Gómez, Valentín García Gutiérrez, Patricia Alcalde-Mellado, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2015
Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin LymphomaVeronika Bachanova, Linda J Burns, Kwang Woo Ahn, et al.
Bone Marrow Transplantation|April 19, 2023
Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART eraAlberto Mussetti, Leyre Bento, Mariana Bastos-Oreiro, et al.
Transplantation and Cellular Therapy|April 27, 2025
Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell LymphomaRoni Shouval, Christopher Strouse, Soyoung Kim, et al.
Pageof 10